# Assessing Induction of Type II (M2) Monocytes/Macrophages in Patients Receiving Gilenya.

> **NCT02225977** · — · COMPLETED · sponsor: **University of Southern California** · enrollment: 125 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Gilenya

## Key facts

- **NCT ID:** NCT02225977
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07-31
- **Primary completion:** 2016-12-31
- **Final completion:** 2017-04-30
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2018-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02225977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02225977, "Assessing Induction of Type II (M2) Monocytes/Macrophages in Patients Receiving Gilenya.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02225977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*